- Home
- TRNO vs PTCT Comparison
TRNO vs PTCT Comparison
Compare TRNO & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRNO
- PTCT
- Stock Information
- Founded
- TRNO 2009
- PTCT 1998
- Country
- TRNO United States
- PTCT United States
- Employees
- TRNO N/A
- PTCT N/A
- Industry
- TRNO Real Estate
- PTCT Biotechnology: Pharmaceutical Preparations
- Sector
- TRNO Finance
- PTCT Health Care
- Exchange
- TRNO Nasdaq
- PTCT Nasdaq
- Market Cap
- TRNO 6.0B
- PTCT 4.8B
- IPO Year
- TRNO 2010
- PTCT 2013
- Fundamental
- Price
- TRNO $57.98
- PTCT $63.76
- Analyst Decision
- TRNO Buy
- PTCT Buy
- Analyst Count
- TRNO 10
- PTCT 14
- Target Price
- TRNO $65.00
- PTCT $67.00
- AVG Volume (30 Days)
- TRNO 654.2K
- PTCT 1.3M
- Earning Date
- TRNO 11-05-2025
- PTCT 11-06-2025
- Dividend Yield
- TRNO 3.56%
- PTCT N/A
- EPS Growth
- TRNO 40.84
- PTCT N/A
- EPS
- TRNO 2.52
- PTCT 7.72
- Revenue
- TRNO $425,998,000.00
- PTCT $1,764,929,000.00
- Revenue This Year
- TRNO $21.56
- PTCT $119.89
- Revenue Next Year
- TRNO $10.82
- PTCT N/A
- P/E Ratio
- TRNO $23.14
- PTCT $8.28
- Revenue Growth
- TRNO 22.17
- PTCT 96.00
- 52 Week Low
- TRNO $48.18
- PTCT $34.57
- 52 Week High
- TRNO $69.20
- PTCT $67.40
- Technical
- Relative Strength Index (RSI)
- TRNO 54.76
- PTCT 65.90
- Support Level
- TRNO $57.78
- PTCT $57.74
- Resistance Level
- TRNO $59.00
- PTCT $67.40
- Average True Range (ATR)
- TRNO 1.04
- PTCT 2.31
- MACD
- TRNO -0.03
- PTCT 0.16
- Stochastic Oscillator
- TRNO 53.78
- PTCT 61.28
About TRNO Terreno Realty Corporation
Terreno Realty Corp is a real estate investment trust engaged in acquiring, owning, and operating industrial real estate in six coastal U.S. markets: Los Angeles, Northern New Jersey/New York City, San Francisco Bay Area, Seattle, Miami, and Washington, D.C. The company invests in several types of industrial real estate, including warehouse/distribution, flex (including light industrial and research and development), transshipment, and improved land.
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.